How GLP-1 analogs are reshaping diabetes care and obesity treatment and unlocking potential in cardiovascular, inflammatory, ...

As demand soared for weight-loss drugs, price signals worked.

The decision counters a proposal by the Biden Administration to reimburse beneficiaries for the weight-loss medications.

The Centers for Medicare and Medicaid Services (CMS) announced Friday it will not be finalizing a rule proposed by the Biden ...

The number of Americans taking cutting-edge weight-loss drugs like Ozempic, Wegovy and Zepbound has skyrocketed in recent ...

The race is under way to make faster, cheaper and better GLP-1 drugs that will go beyond reducing obesity levels to treating ...

Two undergraduate medicine students at University of Galway have led a major study examining how cardioprotective ...

A major new study finds that certain diabetes medications, including GLP-1 and SGLT2 inhibitors, may be linked to a reduced ...

Anecdotal reports suggest drugs like Ozempic may curb not just appetite but also impulsive or addictive behaviour, hinting at ...

While it is understood that the drugs have also proven to be safe and effective for thousands, the negative issues have led ...

The weight-loss drug revolution has arrived, and the food & beverage industry has begun to evolve in response to suppressed ...